Liking GTXI on the Monday Open

Hello Readers and New Subscribers,

As everyone enjoyed their weekend, we touted our 6 stock picks from last week and we watched a huge mover on Friday, GTx, Inc. (NASDAQ: GTXI).

The stock was upgraded Friday morning and surged over 20%.  There ids still a lot of room to profit on this Hormone Development Biopharmaceutical company since analysts are targeting $7.

The company markets FARESTON (toremifene citrate) 60 mg ...

Continue Reading →